نتایج جستجو برای: egfr genes

تعداد نتایج: 454104  

2017
Hong-Xia Tian Xu-Chao Zhang Zhen Wang Jin-Ji Yang Wei-Bang Guo Zhi-Hong Chen Yi-Long Wu

BACKGROUND Drug resistance to targeted therapies occurs in lung cancer, and resistance mechanisms related to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are continuously being discovered. We aimed to establish a novel method for highly parallel multiplexed detection of genetic mutations related to EGFR TKI-resistant lung cancer using Agena iPLEX chemistry and matri...

Journal: :Cancer research 2012
Hirokazu Okayama Takashi Kohno Yuko Ishii Yoko Shimada Kouya Shiraishi Reika Iwakawa Koh Furuta Koji Tsuta Tatsuhiro Shibata Seiichiro Yamamoto Shun-ichi Watanabe Hiromi Sakamoto Kensuke Kumamoto Seiichi Takenoshita Noriko Gotoh Hideaki Mizuno Akinori Sarai Shuichi Kawano Rui Yamaguchi Satoru Miyano Jun Yokota

Activation of the EGFR, KRAS, and ALK oncogenes defines 3 different pathways of molecular pathogenesis in lung adenocarcinoma. However, many tumors lack activation of any pathway (triple-negative lung adenocarcinomas) posing a challenge for prognosis and treatment. Here, we report an extensive genome-wide expression profiling of 226 primary human stage I-II lung adenocarcinomas that elucidates ...

2018
Yanzhuo Luo Bingjin Li Guangxin Zhang Yuxiao He Jeeyoo Hope Bae Fengping Hu Ranji Cui Runhua Liu Zhou Wang Lizhong Wang

Targeted therapies based on EGFR mutations or on the ALK fusion oncogene have become the standard treatment for certain patients with lung adenocarcinoma (LUAD). However, most LUAD patients have no EGFR mutation or ALK fusion, and their oncogenetic alterations remain to be characterized. Here we conducted an integrated analysis of public datasets to assess the genomic alterations of 23 highly l...

2016
Orsolya Módos Henning Reis Christian Niedworok Herbert Rübben Attila Szendröi Szász Marcell A. József Tímár Kornélia Baghy Ilona Kovalszky Tomasz Golabek Piotr Chlosta Krzysztof Okon Benoit Peyronnet Romain Mathieu Shahrokh F. Shariat Péter Hollósi Péter Nyirády Tibor Szarvas

PURPOSE Targeted therapy represents an attractive alternative for rare tumors such as urachal carcinoma (UrC). The aim of this study was to assess the mutations of the most commonly affected 5 genes in the targetable EGFR-pathway in UrC and comapre their frequencies to those of found in urothelial and colorectal cancer. MATERIALS AND METHODS Mutational hot-spots of selected genes were tested ...

Journal: :General Physiology and Biophysics 2021

Atrial fibrillation (AF) is a common cardiac arrhythmia that induces serious complications. However, pharmacological treatments of AF remain challenging. This study aimed to screen crucial long non-coding RNAs (lncRNAs), microRNAs (miRNAs) and messenger RNA (mRNAs) for using the microarray datasets (lncRNAs mRNAs: GSE79768, GSE115574; miRNAs: GSE68475) collected from Gene Expression Omnibus dat...

Journal: :Cancer research 2005
Hisayuki Shigematsu Takao Takahashi Masaharu Nomura Kuntal Majmudar Makoto Suzuki Huei Lee Ignacio I Wistuba Kwun M Fong Shinichi Toyooka Nobuyoshi Shimizu Takehiko Fujisawa John D Minna Adi F Gazdar

Mutations in the epidermal growth factor receptor gene (EGFR) in lung cancers predict for sensitivity to EGFR kinase inhibitors. HER2 (also known as NEU, EGFR2, or ERBB2) is a member of the EGFR family of receptor tyrosine kinases and plays important roles in the pathogenesis of certain human cancers, and mutations have recently been reported in lung cancers. We sequenced the tyrosine kinase do...

2011
Hirokazu Okayama Takashi Kohno Yuko Ishii Yoko Shimada Kouya Shiraishi Reika Iwakawa Koh Furuta Koji Tsuta Tatsuhiro Shibata Seiichiro Yamamoto Shun-ichi Watanabe Hiromi Sakamoto Kensuke Kumamoto Seiichi Takenoshita Noriko Gotoh Hideaki Mizuno Akinori Sarai Shuichi Kawano Rui Yamaguchi Satoru Miyano Jun Yokota

Activation of the EGFR, KRAS, and ALK oncogenes defines 3 different pathways of molecular pathogenesis in lung adenocarcinoma. However, many tumors lack activation of any pathway (triple-negative lung adenocarcinomas) posing a challenge for prognosis and treatment. Here, we report an extensive genome-wide expression profiling of 226 primary human stage I–II lung adenocarcinomas that elucidates ...

2013
HIROAKI KATO TOKUZO ARAO KAZUKO MATSUMOTO YOSHIHIKO FUJITA HIDEHARU KIMURA HIDETOSHI HAYASHI KOUHEI NISHIKI MITSURU IWAMA OSAMU SHIRAISHI ATSUSHI YASUDA MASAYUKI SHINKAI MOTOHIRO IMANO HARUHIKO IMAMOTO TAKUSHI YASUDA KIYOTAKA OKUNO HITOSHI SHIOZAKI KAZUTO NISHIO

Molecular targeted therapy is expected to be a promising therapeutic approach for the treatment of esophageal squamous cell carcinoma (ESCC); however, the gene amplification status of molecular targeted genes in ESCC remains largely unclear. The gene amplification of EGFR, HER2, FGFR2 and MET was examined using a real-time PCR-based copy number assay of 245 ESCC surgical specimens of formalin-f...

Journal: :biomacromolecular journal 2015
mehdi pooladi

egfr is a key molecule in cancer cells. egfr signaling was shown to promote tumor cell proliferation and survival, invasion and angiogenesis and mediate resistance to treatment, including ionizing radiation in preclinical models. we extracted proteins from astrocytoma (iii and iv) oligodendroglioma(iv) tumors and normal brain tissues and then evaluated the protein purity by bradford test and sp...

Journal: :Neuro-oncology 2008
Nikola Holtkamp Elke Malzer Jan Zietsch Ali Fuat Okuducu Jana Mucha Christian Mawrin Victor-F Mautner Hans-Ulrich Schildhaus Andreas von Deimling

Malignant peripheral nerve sheath tumors (MPNSTs) are sarcomas with poor prognosis and limited treatment options. Evidence for a role of epidermal growth factor receptor (EGFR) and receptor tyrosine kinase erbB2 in MPNSTs led us to systematically study these potential therapeutic targets in a larger tumor panel (n = 37). Multiplex ligation-dependent probe amplification and fluorescence in situ ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید